Drugs / piperacillin/tazobactam
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07236944 Comparator | Dec 2025 → Mar 2029 expected | bacterial urinary tract infection | Uppsala University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | piperacillin/tazobactam | “Penicillins; ampicillin, piperacillin/tazobactam, 2) cephalosporins” NCT07236944 ↗ |
| Route | Intravenous | “Intravenous antibiotics: 1) Penicillins; ampicillin, piperacillin/tazobactam” NCT07236944 ↗ |